Answers are grounded in this paper and cite their sources.
Hydrogen reduction and re-oxidation process improved morphology and reduced particle size in MoO3 powders.
An optimum route to fabricate the MoO3 nanoparticles with modified morphology was investigated. Microstructure analysis for the MoO3 powder prepared by high-energy ball milling process for 25 h showed that the plate-shaped raw powders are mostly converted into equiaxed fine particles, but exist as large agglomerates. However, the powder fabricated by the hydrogen reduction at 775℃ of raw powder and re-oxidation at 450℃ exhibits equiaxed fine particles with a size of about 260 nm and relatively small agglomerates. Additionally, the re-oxidized particles show a unimodal particle size distribution with measured values ranging from 0.18 to 0.42 μm. These results indicated that the reduction and re-oxidation process can significantly decrease the particle size and modify the powder morphology into an equiaxed shape.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: